STOCK TITAN
  1. Home
  2. Sec-filings
  3. VICR
  4. [144] VICOR CORP SEC Filing

VICR (NASDAQ: VICR) insider and institutional 10b5-1 sales detailed

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

Insider sales reported for VICR via Form 144 and 10b5-1 plans. The excerpt lists multiple disposition dates and share quantities sold under 10b5-1 instructions by Patrizio Vinciarelli and institutional holders. Examples include 20,000 shares sold on 06/01/2026 for $6,437,096.00 and earlier multi‑day sales in March–April 2026.

The filing itemizes numerous executed sales with corresponding gross proceeds; sale amounts and proceeds are presented per transaction in the excerpt.

Positive

  • None.

Negative

  • None.

Insights

Multiple systematically executed 10b5-1 sales by a named insider and institutions are listed.

The excerpt enumerates discrete sale dates, share counts, and gross proceeds tied to 10b5-1 instructions for Patrizio Vinciarelli and named institutional holders. Each row shows the transaction date, number of shares, and a proceeds figure.

These entries document routine dispositions; cash‑flow treatment and any remaining holdings are not shown in the provided excerpt. Subsequent filings may disclose additional position context.

Sale example 20,000 shares sold on 06/01/2026
Proceeds example $6,437,096.00 gross proceeds for 20,000 shares on 06/01/2026
Large single-day sale 50,000 shares sold on 04/15/2026 with proceeds $9,660,511.00
Institutional sale example 3,500 shares Brigham and Women's Hospital on 05/14/2026 for $1,043,623.00
Aggregate sample day 40,000 shares sold on 04/16/2026 for $7,905,592.00
10b5-1 regulatory
"10b5-1 Sales for PATRIZIO VINCIARELLI 25 Frontage Road Andover MA"
A 10b5-1 plan is a pre-set schedule that lets company insiders buy or sell shares according to written instructions made when they do not possess material, nonpublic information. Think of it as a timed automatic payment for stock trades: it helps insiders avoid accusations of trading on secret information and gives outside investors a clearer signal about whether sales are routine or potentially informative about the company’s prospects.
Form 144 regulatory
"Filer Information | 144: Filer Information"
Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.
Founders Shares financial
"Common | 11/10/1981 | Founders Shares | Issuer"
Founders shares are a special block of a company’s stock originally given to the people who started the business; they often carry extra voting power or favorable terms compared with regular shares. For investors, these shares matter because they concentrate control and influence how future funding, ownership dilution, and decision-making will play out—think of founders shares as the steering wheel that can steer a company’s direction even as more passengers (investors) climb aboard.
Gross proceeds financial
"20000 | 6437096.00"
The total amount of cash a company receives from a financing event or sale before any fees, expenses, taxes or deductions are taken out. Investors watch gross proceeds because it shows the raw scale of new capital being raised—think of it as the paycheck amount before withholdings—which helps assess how much funding is available for operations, growth, debt payoff or how much shareholder dilution might occur once costs are removed.
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

Source: View Original Filing on SEC EDGAR

FAQ

What sales of VICR shares does the Form 144 excerpt show?

The excerpt shows multiple executed sales of Common shares under 10b5-1 plans. It lists transaction dates, share counts and gross proceeds for each sale, including examples such as 20,000 shares on 06/01/2026 for $6,437,096.00.

Who is the primary insider listed in the VICR Form 144 excerpt?

The primary insider named is Patrizio Vinciarelli. The excerpt repeatedly attributes 10b5-1 sales to him with dates and amounts spanning March through June 2026.

Are the sales in the excerpt part of a 10b5-1 trading plan?

Yes. Many rows are labeled as 10b5-1 Sales, indicating transactions executed under pre-established trading plans. Each listed sale includes shares sold and the corresponding gross proceeds amount.

Does the excerpt show proceeds for each transaction?

Each transaction row in the excerpt includes a proceeds figure. For example, a 20,000 share sale on 05/29/2026 shows proceeds of $6,557,429.00, and a 50,000 share sale on 04/15/2026 shows $9,660,511.00.

Are institutional holders listed in the sales excerpt for VICR?

Yes. The excerpt lists institutional or named entities such as Brigham and Women's Hospital and Lahey Hospital & Medical Center with specific share counts and proceeds on 05/14/2026 (3,500 shares each).